iifl-logo-icon 1

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Wockhardt’s antibiotic gets Fast Track designation from USFDA

7 Oct 2024 , 01:54 PM

Wockhardt stock rose on October 7 after the US Food and Drug Administration granted it “fast track designation” for antibiotics used to treat urinary tract infections.

WCK 6777 has also completed a Phase I research undertaken by the National Institutes of Health in the United States, according to the report.

However, later in the day, the counter was trading 3.16% lower at ₹935, against the previous close of ₹965.50 on NSE. The counter touched an intraday high and low of ₹985, and ₹917.25, respectively.

The increase occurred after the company stated in an exchange filing on October 7 that, recognising its potential to meet significant unmet medical needs, the US FDA recently granted Fast Track designation to WCK 6777 for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis, and complicated intraabdominal infections (cIAI).

WCK 6777 is the only once-a-day antibiotic in the global pipeline designated for outpatient parenteral antimicrobial therapy (OPAT), according to the company.

The business is developing many novel antibiotics to address difficult-to-treat drug-resistant bacterial infections that cause antimicrobial resistance (AMR).

Earlier this month, the pharmaceutical business said that one of its investigational drugs, Zaynich, effectively treated critically ill patients with drug-resistant meningitis.

Wockhardt stock has achieved multibagger gains of 104.92% in 2024 thus far. According to BSE data, the stock has risen by 117.71% during the last three years.

For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • Wockhardt
  • Wockhardt Approval
  • Wockhardt news
  • Wockhardt Updates
  • Wockhardt USFDA
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Most Read News

Niva Bupa IPO hits complete subscription
8 Nov 2024|03:34 PM
Swiggy IPO Fully Subscribed
8 Nov 2024|03:16 PM
ACME Solar IPO fully subscribed on Day 3
8 Nov 2024|02:46 PM
Zinka Logistics IPO Details
8 Nov 2024|02:36 PM
Sensex and Nifty in Red on November 8, 2024
8 Nov 2024|01:14 PM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp